Biotechnology Stocks I Performance Guide: Kiniksa Pharmaceuticals, Ltd. (KNSA)
KNSA has no dividends
Table and Chart of KNSA Performance
See what a $1,000 investment in KNSA is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| KNSA Returns | |
|---|---|
| Start Date | Jun-29-2018 |
| Start Price | $17.35 |
| End Date | Dec-01-2023 |
| End Price | $16.81 |
| # Prices | 67 |
| Min Date | Oct-31-2019 |
| Min Price | $7.05 |
| Max Date | Dec-31-2018 |
| Max Price | $28.09 |
| Total Return | -3.11% |
| Annualized Return | -0.56% |
| Current Value of $1,000 Purchase | $969 |
| Number Returns | 2,211 |
| Average Return | -1.54% |
| Number Profitable Returns | 873 |
| Percent Profitable Returns | 39.48% |
| Number Unprofitable Returns | 1,338 |
| Percent Unprofitable Returns | 60.52% |
| Profitable to Unprofitable Returns Ratio | 0.65 |
| KNSA Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,183,091,000 | Price to Sales | 4.76 |
| Earnings per Share | $-0.1100 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.917 |
| PRICE DATA | |
| 52 Week High | $20.65 |
| 52 Week Low | $10.29 |
| Analyst Target Price | $26.2 |
| 50-Day Moving Average | $15.99 |
| 200-Day Moving Average | $14.82 |
| FINANCIAL DATA | |
| Revenue per Share | $3.56 |
| Revenue | $248,748,000 |
| Profit Margin | -2.69% |
| Return on Equity | -0.017% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
KNSA Compare Returns with S&P 500
KNSA Trendline Chart